132 related articles for article (PubMed ID: 17116943)
1. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.
Bewick MA; Conlon MS; Lafrenie RM
J Clin Oncol; 2006 Dec; 24(36):5645-51. PubMed ID: 17116943
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer.
Bewick MA; Conlon MS; Lafrenie RM
Breast Cancer Res Treat; 2008 Sep; 111(1):93-101. PubMed ID: 17922231
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients.
Chang-Claude J; Popanda O; Tan XL; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Ambrosone CB
Clin Cancer Res; 2005 Jul; 11(13):4802-9. PubMed ID: 16000577
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
Jaremko M; Justenhoven C; Schroth W; Abraham BK; Fritz P; Vollmert C; Illig T; Simon W; Schwab M; Brauch H
Pharmacogenet Genomics; 2007 Jul; 17(7):529-38. PubMed ID: 17558308
[TBL] [Abstract][Full Text] [Related]
6. An association of polymorphism of DNA repair genes XRCC1 and XRCC3 with colorectal cancer.
Krupa R; Blasiak J
J Exp Clin Cancer Res; 2004 Jun; 23(2):285-94. PubMed ID: 15354414
[TBL] [Abstract][Full Text] [Related]
7. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
Ryk C; Kumar R; Thirumaran RK; Hou SM
Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
[TBL] [Abstract][Full Text] [Related]
12. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population.
Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
Breast Cancer Res Treat; 2007 Jun; 103(2):209-17. PubMed ID: 17063276
[TBL] [Abstract][Full Text] [Related]
13. Association of cyclin D1 genotype with breast cancer risk and survival.
Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
[TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; Selvaggi G; Gregori D; DeMarchi M; Scagliotti GV
Clin Cancer Res; 2007 May; 13(10):2876-81. PubMed ID: 17504986
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.
Moreno V; Gemignani F; Landi S; Gioia-Patricola L; Chabrier A; Blanco I; González S; Guino E; Capellà G; Canzian F
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2101-8. PubMed ID: 16609022
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in XRCC1, OGG1, APE1 and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists.
Andreassi MG; Foffa I; Manfredi S; Botto N; Cioppa A; Picano E
Mutat Res; 2009 Jun; 666(1-2):57-63. PubMed ID: 19393248
[TBL] [Abstract][Full Text] [Related]
17. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan.
Yen CY; Liu SY; Chen CH; Tseng HF; Chuang LY; Yang CH; Lin YC; Wen CH; Chiang WF; Ho CH; Chen HC; Wang ST; Lin CW; Chang HW
J Oral Pathol Med; 2008 May; 37(5):271-7. PubMed ID: 18410587
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.
Krupa R; Synowiec E; Pawlowska E; Morawiec Z; Sobczuk A; Zadrozny M; Wozniak K; Blasiak J
Exp Mol Pathol; 2009 Aug; 87(1):32-5. PubMed ID: 19426727
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
